Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Neurology
•
Child Neurology
•
Neuro-immunology
What criteria do you use to differentiate between MOGAD and MS in pediatric patients?
Related Questions
How does your decision to use high-efficacy disease-modifying treatments (HET) differ, if at all, when treating late-onset relapsing-remitting multiple sclerosis?
When do you switch to a different DMT in multiple sclerosis patients planning for pregnancy?
How would you approach a toddler with alternating head tilt episodes lasting for weeks?
When do you consider cannabidiol for treatment of epilepsy?
Would you start antiseizure medications in tuberous sclerosis before seizure onset?
What are your preferred anti-seizure medications for Doose syndrome?
Do you consider steroid-sparing agents for treatment of patients with steroid responsive relapsed Hashimoto Encephalopathy?
How do you counsel parents of patients with Autism Spectrum Disorder regarding the limitations of medications without engaging in behavioral or family interventions?
In a neonate with cerebral sinus venous thrombosis who is fluid-limited by renal or cardiac disease, do you recommend hyperhydration before anticoagulation?
How do you decide when to pursue genetic testing for cerebral palsy?
